Ali Health HKG:0241 – Hong Kong Blue Chip stock
Ali Health (HKG:0241)
Hong Kong Blue Chip Stock • Sector: Health
Next ex-dividend date: No Dividend
Alibaba Health Information Technology Ltd (0241.HK) is an investment holding company mainly engaged in providing internet solutions for the medical and pharmaceutical industry. The Company is also involved in the development of pharmaceutical and healthcare product and service sales business, the operation of a pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data. Ali Health is Alibaba Group’s (9988.HK)healthcare flagship platform.
Stock Value Score
This score indicates whether the stock currently appears undervalued, fairly priced, or expensive,
based on key valuation metrics such as earnings, book value, and cash flow.
| P/E ratio | 37.54 |
| P/B ratio | 3.94 |
| EPS | 0.13 |
| Beta | 2.49 |
Beta above 1 suggests higher volatility. Below 1 suggests more stability relative to the market.
Based on current valuation metrics, the stock appears .
Future changes in earnings, cash flow, or price could materially shift this assessment.
Champion Members see the full 3-Pillar scorecard:
Dividend Growth,
Dividend Safety,
Stock Value.
